Chlorthalidone

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2074 publications

Diagnosis and Management of Resistant Hypertension: A Review.

Diagnosis and Management of Resistant Hypertension: A Review.

Journal: JAMA
Published: March 23, 2026

Unmasking of a Heterozygous SLC12A3 Variant.

Unmasking of a Heterozygous SLC12A3 Variant.

Journal: Kidney medicine
Published: March 02, 2026

2024 Thai guidelines on the treatment of hypertension.

2024 Thai guidelines on the treatment of hypertension.

Journal: Asian biomedicine : research, reviews and news
Published: February 23, 2026

Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT.

Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: February 20, 2026

Per-Protocol Analysis of Chlorthalidone Versus Hydrochlorothiazide for Cardiovascular Event Prevention-Diuretic Comparison Project.

Per-Protocol Analysis of Chlorthalidone Versus Hydrochlorothiazide for Cardiovascular Event Prevention-Diuretic Comparison Project.

Journal: Journal of the American Heart Association
Published: January 30, 2026

Innovative Analytical Methodologies for Quantification of Efonidipine HCl and Chlorthalidone: A Critical Review.

Innovative Analytical Methodologies for Quantification of Efonidipine HCl and Chlorthalidone: A Critical Review.

Journal: Critical reviews in analytical chemistry
Published: December 19, 2025

Hydrochlorothiazide and chlorthalidone use and glaucoma risk: pharmacovigilance analysis and nationwide cohort study.

Hydrochlorothiazide and chlorthalidone use and glaucoma risk: pharmacovigilance analysis and nationwide cohort study.

Journal: Frontiers in pharmacology
Published: December 15, 2025

Acute Kidney Injury from Mononuclear Cell-Predominated Interstitial Nephritis After Introduction of a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report.

Acute Kidney Injury from Mononuclear Cell-Predominated Interstitial Nephritis After Introduction of a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report.

Journal: The American journal of case reports
Published: December 07, 2025

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).

Journal: Translational and clinical pharmacology
Published: December 05, 2025

Exploring lactoferrin as an innovative covalently immobilized chiral selector for the selective separation of pharmaceutical enantiomers using HPLC.

Exploring lactoferrin as an innovative covalently immobilized chiral selector for the selective separation of pharmaceutical enantiomers using HPLC.

Journal: Analytica chimica acta
Published: November 11, 2025

Projected Savings for Urolithiasis Medications Purchased Through the Mark Cuban Cost Plus Drug Company in Medicare.

Projected Savings for Urolithiasis Medications Purchased Through the Mark Cuban Cost Plus Drug Company in Medicare.

Journal: Urology practice
Published: October 23, 2025

Green and white analytical chemistry: Advances, comparisons, future perspectives, and a proposal for green financing model for analytical chemistry.

Green and white analytical chemistry: Advances, comparisons, future perspectives, and a proposal for green financing model for analytical chemistry.

Journal: Journal of pharmaceutical sciences
Published: August 19, 2025
Showing 1-12 of 2,074

Last Updated: 04/28/2026